Very early life microbiome and metabolome correlates with primary vaccination variability in children

Area of Science:

• Microbiome research
• Immunology
• Pediatric health

Background:

• The early life microbiome plays a critical role in immune system development.
• Antibiotic exposure can disrupt microbial communities and potentially impair vaccine efficacy.
• Understanding factors influencing infant immune responses to vaccination is crucial for public health.

Purpose of the Study:

• To investigate the distinct maturation patterns of the gut and nasopharyngeal microbiomes in infants.
• To explore the relationship between early-life microbiome composition, antibiotic exposure, and vaccine responsiveness.
• To identify microbial and metabolic factors associated with varying levels of vaccine-induced antibodies.

Main Methods:

• Simultaneous analysis of stool and nasopharyngeal samples to characterize microbiome composition.
• Assessment of early-life antibiotic exposure history.
• Measurement of vaccine-induced antibody levels.
• Quantification of serum metabolites, including phenylpyruvic acid.

Main Results:

• Stool and nasopharyngeal microbiomes exhibit divergent maturation timelines and compositions.
• Early-life antibiotic exposure may negatively impact vaccine responsiveness.
• Bacteria producing lipopolysaccharide (a TLR4 agonist) in the gut and/or nasopharynx may enhance vaccine protection.
• Infants with lower vaccine-induced antibody levels show increased serum phenylpyruvic acid, suggesting higher oxidative stress.

Conclusions:

• Local mucosal factors influence the distinct development of the gut and respiratory microbiomes.
• The early-life microbiome, particularly the presence of specific bacterial components, may serve as a natural adjuvant, improving vaccine efficacy.
• Metabolic alterations, such as increased oxidative stress, are associated with diminished vaccine responses in infants.